News | October 09, 2013

Cianna Medical Receives Approval in Japan for SAVI Breast Brachytherapy

SAVI is the first commercially available intracavitary APBI catheter in Japan

October 9, 2013 — Cianna Medical Inc. announced approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its strut adjusted volume implant (SAVI) applicator in Japan. SAVI delivers accelerated partial breast irradiation (APBI), a five-day course of targeted radiation for early-stage breast cancer patients. The company has partnered with MC Medical Inc., a subsidiary of Mitsubishi Corporation, to bring SAVI to the Japanese healthcare market.

"Entry into Japan is core to our initiative to make SAVI available wherever there is an emergent call to action regarding the treatment of early-stage breast cancer," said Jill Anderson, president and CEO, Cianna Medical. "SAVI uniquely allows women with early-stage breast cancer to be treated in a shorter time frame with less complications, empowering them to reclaim control of their lives more quickly. MC Medical is the ideal partner to convey SAVI's benefits to the Japanese medical community."

According to research, breast cancer rates in Japan will rise by an estimated 24 percent by 2019 to reach 57,000 women compared to 46,000 cases in 2010.  SAVI's strut-based design allows physicians to deliver customized radiation based on patient-specific anatomy. In Japan, where women have relatively smaller breasts, SAVI could make APBI available to a broader swath of patients.

SAVI has been in clinical use in the United States since 2006. The applicator received its CE marking in 2009 and has been in clinical use in Turkey and Poland since 2011. More than 14,000 women have been treated with SAVI.

For more information: www.cinannamedical.com

Related Content

Breast Cancer Places Greater Financial Burden on Black Women
News | Women's Health | May 16, 2018
Having breast cancer placed a significantly greater financial strain on black women than white women, according to a...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Videos | Breast Imaging | May 08, 2018
ITN Associate Editor Jeff Zagoudis speaks with Karen Hou, M.D., breast radiologist at Northwestern Medicine Central D
3D-4D ultrasound of a fetus imaged with a GE Volusion E10 system. It shows the yoke sac. This is a baby ultrasound, also referred to as fetal ultrasound or prenatal ultrasound.

3D-4D ultrasound of a fetus imaged with a GE Volusion E10 system. It shows the yoke sac.

Feature | Ultrasound Women's Health | May 07, 2018
Below is a collection of prenatal ultrasound images from the ITN archive.
Hologic Clarity

Photo courtesy of Hologic.

Feature | Breast Imaging | May 03, 2018 | By Melinda Taschetta-Millane
The global breast imaging market is expected to reach $7.3 billion by 2024, according to a new report by Grand View R
Guideline updates and clinical research highlight the need for improved understanding of gender differences by clinicians and patients
Feature | Women's Health | May 03, 2018 | By Jeff Zagoudis
Clinical research has revealed men and women often have different presentations for cardiovascular disease (CVD).
Computer Error Leads to 450,000 Missed U.K. Breast Screening Invites
News | Mammography | May 02, 2018
Since 2009, approximately 450,000 women around age 70 in the United Kingdom did not receive final breast screening...
Overlay Init